Kontakt
Investor Relations
![graphic](https://nswow-imageresizer.azurewebsites.net/remote/report.bbbiotech.ch/Q321/app/uploads/b2a937fa-4c88-4ced-a5bf-53b51b7ba9a2.jpeg?width=1240&crop=%280%2C79%2C845%2C714%29&quality=60)
![graphic](https://nswow-imageresizer.azurewebsites.net/remote/report.bbbiotech.ch/Q321/app/uploads/2608f128-3d69-4463-9bee-6f885f8bbe5a.jpeg?width=1240&crop=%280%2C74%2C848%2C712%29&quality=60)
![graphic](https://nswow-imageresizer.azurewebsites.net/remote/report.bbbiotech.ch/Q321/app/uploads/d647017d-7aaa-4399-a8f3-893495295c05.jpeg?width=1240&crop=%280%2C161%2C683%2C675%29&quality=60)
Media Relations
![graphic](https://nswow-imageresizer.azurewebsites.net/remote/report.bbbiotech.ch/Q321/app/uploads/e3961a61-49ea-436a-8a61-d76c1b433711.jpeg?width=1240&crop=%280%2C57%2C683%2C571%29&quality=60)
BB Biotech AG
Schwertstrasse 6
CH-8200 Schaffhausen
E-Mail info@bbbiotech.com
www.bbbiotech.com
Bellevue Asset Management AG
Seestrasse 16/Postfach
CH-8700 Küsnacht
Telefon +41 44 267 67 00
E-Mail info@bellevue.ch
www.bellevue.ch
BB biotech Newsletter
Möchten Sie zukünftig regelmässig über BB Biotech informiert werden? Melden Sie sich hier für unseren Newsletter an.
Zur ANmeldung